1. Home
  2. AMPH vs ULCC Comparison

AMPH vs ULCC Comparison

Compare AMPH & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ULCC
  • Stock Information
  • Founded
  • AMPH 1996
  • ULCC 1994
  • Country
  • AMPH United States
  • ULCC United States
  • Employees
  • AMPH N/A
  • ULCC N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ULCC Air Freight/Delivery Services
  • Sector
  • AMPH Health Care
  • ULCC Consumer Discretionary
  • Exchange
  • AMPH Nasdaq
  • ULCC Nasdaq
  • Market Cap
  • AMPH 1.2B
  • ULCC 1.1B
  • IPO Year
  • AMPH 2014
  • ULCC 2021
  • Fundamental
  • Price
  • AMPH $25.99
  • ULCC $4.40
  • Analyst Decision
  • AMPH Buy
  • ULCC Hold
  • Analyst Count
  • AMPH 6
  • ULCC 9
  • Target Price
  • AMPH $35.50
  • ULCC $5.63
  • AVG Volume (30 Days)
  • AMPH 454.6K
  • ULCC 3.6M
  • Earning Date
  • AMPH 11-05-2025
  • ULCC 10-28-2025
  • Dividend Yield
  • AMPH N/A
  • ULCC N/A
  • EPS Growth
  • AMPH N/A
  • ULCC N/A
  • EPS
  • AMPH 2.68
  • ULCC N/A
  • Revenue
  • AMPH $722,679,000.00
  • ULCC $3,778,000,000.00
  • Revenue This Year
  • AMPH $1.37
  • ULCC $1.43
  • Revenue Next Year
  • AMPH $6.93
  • ULCC $13.45
  • P/E Ratio
  • AMPH $9.68
  • ULCC N/A
  • Revenue Growth
  • AMPH 1.37
  • ULCC 4.60
  • 52 Week Low
  • AMPH $20.39
  • ULCC $2.89
  • 52 Week High
  • AMPH $53.96
  • ULCC $10.26
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 38.56
  • ULCC 43.60
  • Support Level
  • AMPH $25.96
  • ULCC $4.14
  • Resistance Level
  • AMPH $27.31
  • ULCC $5.56
  • Average True Range (ATR)
  • AMPH 0.73
  • ULCC 0.32
  • MACD
  • AMPH -0.14
  • ULCC -0.10
  • Stochastic Oscillator
  • AMPH 6.14
  • ULCC 18.66

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

Share on Social Networks: